McGill University researcher Dr. Bernard Belleau developed antiviral drug 3TC (Lamivudine), a critical component of Hepatitis B and HIV therapies

, , , ,

In 1989, McGill University researcher Dr. Bernard Belleau developed the antiviral drug 3TC (Lamivudine), which became a critical component of Hepatitis B and HIV therapies.

Tags:

,

Source: McGill University
Credit:

Visit News/History Source